Fas ligand

Fas Ligand

Diagram of Fas signaling pathway

Fas ligand (FasL) is a type-II transmembrane protein that belongs to the tumor necrosis factor (TNF) family. It plays a crucial role in the regulation of the immune system and the induction of apoptosis. Fas ligand is primarily expressed on the surface of activated T cells and natural killer cells.

Structure

Fas ligand is a homotrimeric protein, meaning it forms a complex of three identical subunits. Each subunit consists of an extracellular domain, a transmembrane domain, and a short cytoplasmic tail. The extracellular domain is responsible for binding to its receptor, Fas receptor (also known as CD95), which is a member of the TNF receptor superfamily.

Function

Fas ligand is involved in the induction of apoptosis, a form of programmed cell death. When Fas ligand binds to the Fas receptor on the surface of a target cell, it triggers a cascade of intracellular signaling events that lead to cell death. This process is essential for maintaining immune system homeostasis and preventing autoimmune diseases.

Apoptosis Induction

Upon binding of Fas ligand to Fas receptor, the receptor trimerizes and recruits the adaptor protein FADD (Fas-associated death domain). FADD then recruits procaspase-8, forming the death-inducing signaling complex (DISC). Activation of procaspase-8 leads to the activation of downstream effector caspases, such as caspase-3, ultimately resulting in apoptosis.

Overview of signal transduction pathways, including Fas signaling

Role in the Immune System

Fas ligand is critical for the regulation of the immune response. It is involved in the elimination of activated lymphocytes and the maintenance of immune privilege in certain tissues, such as the eye and testis. Fas ligand-mediated apoptosis is also important for the deletion of autoreactive T cells in the thymus, preventing the development of autoimmune diseases.

Clinical Significance

Dysregulation of Fas ligand expression or function can lead to various pathological conditions. Overexpression of Fas ligand can contribute to tissue damage in autoimmune diseases, while insufficient Fas ligand activity can result in the accumulation of autoreactive lymphocytes. Mutations in the Fas or Fas ligand genes are associated with autoimmune lymphoproliferative syndrome (ALPS), a disorder characterized by lymphadenopathy, splenomegaly, and autoimmune cytopenias.

Related Pages

• Apoptosis
• Fas receptor
• Tumor necrosis factor
• Immune system
• Autoimmune disease